Daiwa Securities Group Inc. - GENERATION BIO CO ownership

GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of GENERATION BIO CO
ValueSharesWeighting
Q3 2023$10.0%1940.0%0.00%
Q2 2023$10.0%1940.0%0.00%
Q1 2023$10.0%1940.0%0.00%
Q4 2022$1
-99.9%
1940.0%0.00%
Q3 2022$1,0000.0%1940.0%0.00%
Q2 2022$1,0000.0%1940.0%0.00%
Q1 2022$1,0000.0%1940.0%0.00%
Q4 2021$1,000
-80.0%
1940.0%0.00%
Q3 2021$5,000
+66.7%
194
+79.6%
0.00%
Q2 2021$3,0000.0%1080.0%0.00%
Q1 2021$3,000
+50.0%
108
+24.1%
0.00%
Q4 2020$2,000870.00%
Other shareholders
GENERATION BIO CO shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 8,279,484$31,379,2444.86%
GREAT POINT PARTNERS LLC 1,022,537$3,875,4150.71%
Artal Group S.A. 2,814,191$10,6660.46%
PFM Health Sciences, LP 2,514,443$9,529,7390.45%
Yiheng Capital Management, L.P. 1,666,181$6,314,8260.32%
SECTORAL ASSET MANAGEMENT INC 356,740$1,352,0450.26%
EcoR1 Capital, LLC 2,046,867$7,757,6260.26%
Bellevue Group AG 3,617,080$13,708,7330.22%
SVB FINANCIAL GROUP 25,034$94,8790.18%
CORNERCAP INVESTMENT COUNSEL INC 37,681$142,8110.03%
View complete list of GENERATION BIO CO shareholders